Quest Diagnostics Incorporated (NYSE:DGX) will look for acquisitions. Stephen Rusckowski, Chairman, President and Chief Executive Officer said, "we will continue to grow both organically and through acquisitions, and we believe the acquisition growth that we've seen will continue to be greater than 2% per annum. We're always looking for accretive strategic acquisitions.

And if you look at our history, we have grown that 2%. And then you couple that with our organic opportunities, and that will deliver the growth we expect for the company. And that's underpinned with strong operational opportunities.

We look at acquisitions. One is hospital outreach, and we've landed a number of good relationships. And again, Tycho, comes back to you.

It's not just about buying their outreach, but its forming a relationship around the reference testing, which is a large part of advanced diagnostics growth as well. And it's also focused on what we can do around helping to become more efficient in their hospital laboratories, for instance, what we've done with Hackensack Meridian Health care, as an example. So that continues to be a big opportunity for us.

Secondly is we're looking at regional acquisitions where we believe there is a fragmented marketplace where we can consolidate in the course of the last 5, 7 years, we always have a few regional acquisitions that we made".